VLON

Vallon Pharmaceuticals to Present at the Q2 Virtual Investor Summit

Vallon Pharmaceuticals to Participate at the 4th Annual Neuroscience Innovation Forum

Vallon Pharmaceuticals Continues Advancement of Pivotal Study in Lead Development Program, ADAIR, Toward Potential Approval

Vallon Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Update

Vallon Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference

Vallon Pharmaceuticals Appoints Marella Thorell to Board of Directors

Vallon Pharmaceuticals Announces Closing of Initial Public Offering